Market Cap
$1.0B
PRCT
PROCEPT BioRobotics Corp
$17.31 ▲ +1.67%
Prev close $17.02Market cap$1.0B
ConsensusHold
12-mo target$21.64 (+25.0%)
▲ Neutral
Analyst conviction 5/10
Insider Selling Cluster (3 insiders)High Impact Filing (7/10)34 New Institutional Positions13 Institutional Exits Robotics & Automation
Snapshot
The big-picture read on PRCT right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Hold (48%)
Inst. Holders
50 funds
Inst. Value
$838.5M
Inst. Activity
34 buys / 13 sells
Insider Activity
$11.0M buy / $623.8K sell
Insider Net $
$10.4M
Social Sentiment
60° Warm
SEC Reports
10
Price chart 30d -21.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 other
PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation
SAN DIEGO, Oct. 1, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit h
Sep 9, 2026 Insider
Waters Kevin sold 373 shares
EVP, CFO @ $20.95 ($7.8K)
Sep 9, 2026 Insider
Nouri Alaleh sold 297 shares
EVP, CLO, CORP. SEC. @ $20.95 ($6.2K)
Sep 9, 2026 Insider
Templin Barry L sold 373 shares
EVP, Chief Technology Officer @ $20.95 ($7.8K)
Jun 30, 2026 Inst.
WELLINGTON MANAGEMENT GROUP LLP — ADD
1,274,004 shares ($28.8M)
Jun 30, 2026 Inst.
Jun 11, 2026 SEC FEDERATED HERMES, INC. — DOUBLED
1,253,420 shares ($28.3M)
A mixed institutional cluster for PROCEPT BioRobotics in Q3 2025 shows three buyers (including Citadel doubling and UBS
INST-CLUSTER — Impact 4/10
Three EVP-level insiders (CFO, CLO, CTO) at PROCEPT BioRobotics sold small open-market positions on June 8, 2026, totali
CLUSTER — Impact 2/10
Analyst ratings buy % -40.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
48% rate it Buy or better · 21 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 5, 2026 | TD Cowen | MAINTAIN | Buy | 56% |
| Aug 5, 2026 | Piper Sandler | MAINTAIN | Overweight | 54% |
| Aug 5, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
| Aug 5, 2026 | William Blair | DOWNGRADE | Market Perform | 51% |
| Jul 6, 2026 | Truist Securities | DOWNGRADE | Hold | 55% |
| Jun 24, 2026 | Evercore ISI Group | INITIATE | Outperform | 59% |
| Jun 11, 2026 | Leerink Partners | DOWNGRADE | Market Perform | 49% |
| Apr 30, 2026 | Piper Sandler | REITERATE | Overweight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 7 | 10 | 1 | 0 | 48% | |
| Aug 1, 2026 | 4 | 8 | 8 | 1 | 0 | 57% | |
| Jul 1, 2026 | 4 | 11 | 6 | 1 | 0 | 68% | |
| Jun 1, 2026 | 5 | 10 | 5 | 1 | 0 | 71% | |
| May 1, 2026 | 5 | 10 | 5 | 1 | 0 | 71% | |
| Apr 1, 2026 | 5 | 10 | 5 | 1 | 0 | 71% | |
| Mar 1, 2026 | 5 | 10 | 4 | 1 | 0 | 75% | |
| Feb 1, 2026 | 6 | 10 | 4 | 0 | 0 | 80% |
Price targets
Where 11 covering analysts think PRCT trades over the next 12 months.
$21.64 +25.0% upside Strong Buy
Current$17.31 Low$16.00 Median$21.00 High$28.00 11 analysts
$16.00$28.00
Analyst rating Hold· 2.6/5 as of Oct 2, 2026
Social media sentiment
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
60°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
10 SEC filing reports analyzed · 4 bullish, 0 bearish, 1 mixed, 5 neutral · avg impact 4.5/10.
MIXEDINST-CLUSTER4/10
A mixed institutional cluster for PROCEPT BioRobotics in Q3 2025 shows three buyers (including Citad
Jun 11, 2026
NEUTRALCLUSTER2/10
Three EVP-level insiders (CFO, CLO, CTO) at PROCEPT BioRobotics sold small open-market positions on
Jun 10, 2026
NEUTRALCLUSTER2/10
Three PROCEPT executives (CFO, CTO, CLO) sold a combined ~1,000 shares worth ~$28K in open-market tr
Jun 10, 2026
NEUTRALCLUSTER2/10
Three EVP-level insiders at PROCEPT BioRobotics Corp sold a total of $28K worth of shares on June 8,
Jun 10, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
other
PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation
SAN DIEGO, Oct. 1, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit has been filed concerning certain investors in PROC
Oct 1, 2026
short_volume
Short Volume: PRCT — 62.9% short (0.3M / 0.5M)
Short: 337,293 | Exempt: 0 | TRF Vol: 536,598 | Short Ratio: 62.9% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: PRCT — 67.5% short (0.4M / 0.5M)
Short: 363,759 | Exempt: 0 | TRF Vol: 539,221 | Short Ratio: 67.5% | Off-exchange volume (dark pool + OTC)
Sep 22, 2026
other
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT
NEW YORK, Sept. 22, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation ("Proce
Sep 21, 2026
other
PRCT FINAL DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit
SAN FRANCISCO, Sept. 21, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.39 | $-0.42–$-0.34 | -2.2% | +0.0% | 0↑ 9↓ | $0.1B | 10 |
| Next Q | $-0.25 | $-0.29–$-0.23 | 52.0% | +0.0% | 0↑ 9↓ | $0.1B | 10 |
| Current FY | $-1.68 | $-1.82–$-1.62 | 2.3% | +0.0% | 0↑ 10↓ | $0.4B | 11 |
| Next FY | $-1.15 | $-1.53–$-0.82 | 31.4% | +0.0% | 0↑ 10↓ | $0.5B | 11 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.388 | — |
| 7d ago | $-0.388 | — |
| 30d ago | $-0.388 | — |
| 60d ago | $-0.338 | -0.051 |
| 90d ago | $-0.336 | -0.052 |
Institutional ownership
Which big funds own PRCT (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $838.5M total value (37,130,054 shares) as of 2026-Q2. Top holders: BlackRock,, BNP, VANGUARD. Net buying activity: 34 institutions added/increased vs 13 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 4,869,828 | $110.0M | 13.1% | — |
| BNP Paribas Asset Management Holding S.A. | 2,823,849 | $63.8M | 7.6% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,526,802 | $57.1M | 6.8% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,460,802 | $55.6M | 6.6% | — |
| STATE STREET CORP | 1,617,475 | $36.5M | 4.4% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 1,484,163 | $33.5M | 4.0% | — |
| FMR LLC | 1,444,878 | $32.6M | 3.9% | TRIM -68.6% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,274,004 | $28.8M | 3.4% | ADD +47.9% |
| FEDERATED HERMES, INC. | 1,253,420 | $28.3M | 3.4% | DOUBLED +618.6% |
| Jupiter Topco LLC | 1,103,404 | $24.9M | 3.0% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | ADD | 861,605 | 1,274,004 | +47.9% | $28.8M |
| FEDERATED HERMES, INC. | DOUBLED | 174,436 | 1,253,420 | +618.6% | $28.3M |
| FRONTIER CAPITAL MANAGEMENT CO LLC | ADD | 609,857 | 1,091,528 | +79.0% | $24.6M |
| LMR Partners LLP | NEW | — | 721,608 | — | $16.3M |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | ADD | 424,309 | 709,484 | +67.2% | $16.0M |
| Artisan Partners Limited Partnership | TRIM | 1,187,349 | 682,588 | -42.5% | $15.4M |
| MILLENNIUM MANAGEMENT LLC | TRIM | 1,005,458 | 624,312 | -37.9% | $14.1M |
| MORGAN STANLEY | TRIM | 977,407 | 605,407 | -38.1% | $13.7M |
| BLAIR WILLIAM & CO/IL | ADD | 323,935 | 531,724 | +64.1% | $12.0M |
| GOLDMAN SACHS GROUP INC | ADD | 302,044 | 447,537 | +48.2% | $10.1M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
13 insiders, 50 transactions. Net $10.4M — $11.0M bought, $623.8K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Waters Kevin | EVP, CFO | SELL | 373 | $20.95 | $7.8K |
| Sep 9, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | SELL | 297 | $20.95 | $6.2K |
| Sep 9, 2026 | Templin Barry L | EVP, Chief Technology Officer | SELL | 373 | $20.95 | $7.8K |
| Aug 13, 2026 | Waters Kevin | EVP, CFO | AWARD | 40,851 | — | — |
| Aug 13, 2026 | Templin Barry L | EVP, Chief Technology Officer | AWARD | 26,246 | — | — |
| Aug 13, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | AWARD | 31,773 | — | — |
| Aug 13, 2026 | Waters Kevin | EVP, CFO | AWARD | 29,527 | — | — |
| Aug 13, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | AWARD | 22,965 | — | — |
| Aug 13, 2026 | Sharma Pooja | Chief Strat/Marketing Officer | AWARD | 23,622 | — | — |
| Aug 13, 2026 | Sharma Pooja | Chief Strat/Marketing Officer | AWARD | 32,681 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PRCT.
Shares short
7,440,176
Settlement Sep 15, 2026
Change vs prior
+2.6%
Semi-monthly cycle
Days to cover
5.6
At avg daily volume
Of shares outstanding
≈13.0%
Estimate — not % of float
All PRCT filing & press-release reports (10)
- INST-CLUSTER reportJun 11, 2026
- CLUSTER reportJun 10, 2026
- CLUSTER reportJun 10, 2026
- CLUSTER reportJun 10, 2026
- CLUSTER reportMar 19, 2026
- CLUSTER reportMar 12, 2026
- CLUSTER reportMar 9, 2026
- 8-K reportMar 6, 2026
- 8-K reportFeb 26, 2026
- 8-K reportFeb 25, 2026